China: GTJA pilots $39m round in antibody drug firm Mabworks

China: GTJA pilots $39m round in antibody drug firm Mabworks

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter